rofecoxib has been researched along with Disease, Pulmonary in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Angioedema is a recognised side effect of rofecoxib, a cyclo-oxygenase-2 (COX-2) inhibitor." | 7.71 | Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib. ( Kumar, NP; Ramasamy, KA; Snape, J; Wild, G, 2002) |
"Angioedema is a recognised side effect of rofecoxib, a cyclo-oxygenase-2 (COX-2) inhibitor." | 3.71 | Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib. ( Kumar, NP; Ramasamy, KA; Snape, J; Wild, G, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kumar, NP | 1 |
Wild, G | 1 |
Ramasamy, KA | 1 |
Snape, J | 1 |
Chan, PW | 1 |
Omar, KZ | 1 |
Ramanujam, TM | 1 |
2 other studies available for rofecoxib and Disease, Pulmonary
Article | Year |
---|---|
Fatal haemorrhagic pulmonary oedema and associated angioedema after the ingestion of rofecoxib.
Topics: Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Fatal Outcome; Hemor | 2002 |
Successful treatment of unresectable inflammatory pseudotumor of the lung with COX-2 inhibitor.
Topics: Administration, Oral; Child; Cyclooxygenase Inhibitors; Granuloma, Plasma Cell; Humans; Lactones; Lu | 2003 |